Alimera Sciences Ownership
Alimera Sciences holds a total of 54.38 Million outstanding shares. The majority of Alimera Sciences outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Alimera Sciences to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Alimera Sciences. Please pay attention to any change in the institutional holdings of Alimera Sciences as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Alimera |
Alimera Stock Ownership Analysis
About 87.0% of the company shares are held by institutions such as insurance companies. The company last dividend was issued on the 15th of November 2019. Alimera Sciences had 1:15 split on the 15th of November 2019. Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. The company was incorporated in 2003 and is headquartered in Alpharetta, Georgia. Alimera Sciences operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 145 people. For more info on Alimera Sciences please contact the company at 678 990 5740 or go to https://alimerasciences.com.Alimera Sciences Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Alimera Sciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Alimera Sciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Alimera Sciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Jones John Philip over six months ago Acquisition by Jones John Philip of 8750 shares of Alimera Sciences subject to Rule 16b-3 | ||
Morgan Adam over six months ago Disposition of 7000 shares by Morgan Adam of Alimera Sciences at 1.7 subject to Rule 16b-3 | ||
Morgan Adam over six months ago Disposition of 6000 shares by Morgan Adam of Alimera Sciences at 2.1 subject to Rule 16b-3 | ||
Richard Eiswirth over six months ago Acquisition by Richard Eiswirth of 500 shares of Alimera Sciences at 4.437 subject to Rule 16b-3 | ||
Maltz Elliot over a year ago Acquisition by Maltz Elliot of 75000 shares of Alimera Sciences subject to Rule 16b-3 | ||
Wood Todd Michael over a year ago Acquisition by Wood Todd Michael of 125000 shares of Alimera Sciences subject to Rule 16b-3 | ||
John Snisarenko over a year ago Acquisition by John Snisarenko of 50000 shares of Alimera Sciences subject to Rule 16b-3 | ||
Skibsted Russell over a year ago Acquisition by Skibsted Russell of 58000 shares of Alimera Sciences subject to Rule 16b-3 |
Alimera Sciences Outstanding Bonds
Alimera Sciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Alimera Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Alimera bonds can be classified according to their maturity, which is the date when Alimera Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| ATDBCN 3625 13 MAY 51 Corp BondUS01626PAQ90 | View | |
| ATDBCN 45 26 JUL 47 Corp BondUS01626PAG19 | View | |
| ATDBCN 355 26 JUL 27 Corp BondUS01626PAH91 | View | |
| ATDBCN 295 25 JAN 30 Corp BondUS01626PAM86 | View | |
| ATDBCN 38 25 JAN 50 Corp BondUS01626PAN69 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in Alimera Stock
If you are still planning to invest in Alimera Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alimera Sciences' history and understand the potential risks before investing.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |